Celastrol inhibits intestinal lipid absorption by reprofiling the gut microbiota to attenuate high-fat diet-induced obesity
H Hua, Y Zhang, F Zhao, K Chen, T Wu, Q Liu… - Iscience, 2021 - cell.com
Celastrol, a compound extracted from traditional Chinese medicine, has been reported as a
potent anti-obesity agent with controversial mechanisms. Here both C57BL/6J and leptin …
potent anti-obesity agent with controversial mechanisms. Here both C57BL/6J and leptin …
[HTML][HTML] Effects of microbiota on the treatment of obesity with the natural product Celastrol in rats
W Hu, L Wang, G Du, Q Guan, T Dong… - Diabetes & …, 2020 - synapse.koreamed.org
Background Obesity has become one of the most serious issues threatening the health of
humankind, and we conducted this study to examine whether and how celastrol protects …
humankind, and we conducted this study to examine whether and how celastrol protects …
Serum metabolome mediates the antiobesity effect of celastrol-induced gut microbial alterations
S Xu, L Lyu, H Zhu, X Huang, W Xu, W Xu… - Journal of Proteome …, 2021 - ACS Publications
The antiobesity effect of celastrol has been reported in numerous studies, but the underlying
mechanism remains unclear. It is widely accepted that gut dysbiosis is closely related to …
mechanism remains unclear. It is widely accepted that gut dysbiosis is closely related to …
Celastrol-induced weight loss is driven by hypophagia and independent from UCP1
K Pfuhlmann, SC Schriever, P Baumann, DG Kabra… - Diabetes, 2018 - Am Diabetes Assoc
Celastrol, a plant-derived constituent of traditional Chinese medicine, has been proposed to
offer significant potential as an antiobesity drug. However, the molecular mechanism for this …
offer significant potential as an antiobesity drug. However, the molecular mechanism for this …
Celastrol in metabolic diseases: Progress and application prospects
S Xu, Y Feng, W He, W Xu, W Xu, H Yang, X Li - Pharmacological research, 2021 - Elsevier
Metabolic diseases are becoming increasingly common in modern society. Therefore, it is
essential to develop effective drugs or new treatments for metabolic diseases. As an active …
essential to develop effective drugs or new treatments for metabolic diseases. As an active …
Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota
J Jin, J Wang, R Cheng, Y Ren, Z Miao, Y Luo… - Frontiers in …, 2022 - frontiersin.org
This study aimed to evaluate the possible anti-obesity effects of orlistat and ezetimibe and
determine the mechanism by which they alter the composition of gut microbiota and short …
determine the mechanism by which they alter the composition of gut microbiota and short …
[HTML][HTML] Treatment of obesity with celastrol
Despite all modern advances in medicine, an effective drug treatment of obesity has not
been found yet. Discovery of leptin two decades ago created hopes for treatment of obesity …
been found yet. Discovery of leptin two decades ago created hopes for treatment of obesity …
Celastrol alleviates metabolic disturbance in high‐fat diet‐induced obese mice through increasing energy expenditure by ameliorating metabolic inflammation
X Yang, F Wu, L Li, EC Lynch, L Xie… - Phytotherapy …, 2021 - Wiley Online Library
Celastrol, a natural triterpene, has been shown to treat obesity and its related metabolic
disorders. In this study, we first assessed the relationship between the antiobesity effects of …
disorders. In this study, we first assessed the relationship between the antiobesity effects of …
Traditional Chinese Medicine Formula Kang Shuai Lao Pian Improves Obesity, Gut Dysbiosis, and Fecal Metabolic Disorders in High-Fat Diet-Fed Mice
S Gong, T Ye, M Wang, M Wang, Y Li, L Ma… - Frontiers in …, 2020 - frontiersin.org
High-fat diet (HFD)-induced obesity is a risk factor for many metabolic disorders including
cardiovascular diseases, diabetes, and fatty liver disease. Although there are accumulating …
cardiovascular diseases, diabetes, and fatty liver disease. Although there are accumulating …
Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism
Y Zhang, Y Gu, J Jiang, X Cui, S Cheng, L Liu… - npj Science of …, 2022 - nature.com
Stigmasterol (ST) has been shown to improve both lipid and bile acid (BA) metabolism.
However, the mechanism (s) by which ST prevents dyslipidemia via BA metabolism, and the …
However, the mechanism (s) by which ST prevents dyslipidemia via BA metabolism, and the …